Sareum Holdings (SAR)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

18.00p
   
  • Change Today:
      0.50p
  • 52 Week High: 27.50p
  • 52 Week Low: 11.25p
  • Currency: UK Pounds
  • Shares Issued: 138.07m
  • Volume: 142,218
  • Market Cap: £24.85m
  • RiskGrade: 594
  • Beta: 0.64

Sareum Holdings Overview

Sareum discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. Our drug development programmes aim to improve outcomes for patients with serious medical conditions and where current therapies are inadequate.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 6.6  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Sareum Holdings Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-21 n/a (1.72) (2.30)p n/a n/a n/a n/a 0.0%
30-Jun-22 n/a 2.58 (3.20)p n/a n/a n/a n/a 0.0%
30-Jun-23 n/a (4.03) (4.70)p n/a n/a n/a n/a 0.0%
30-Jun-24 n/a (4.60) (4.20)p n/a n/a n/a n/a 0.0%
30-Jun-25 n/a (3.06) (2.40)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Sareum Holdings Company Announcements

Form 8.3 - Oxford Biomedica plc 23-Jan-2026 16:36 RNS
Results of AGM 09-Dec-2025 16:25 RNS
Annual General Meeting Statement 09-Dec-2025 07:00 RNS

Sareum Holdings ShareCast News

Sareum reports progress across pipeline 09-Dec-2025 ShareCast
Sareum halts toxicology study after control-grou... 10-Oct-2025 ShareCast
Sareum starts toxicology studies for lead inhibi... 29-May-2025 ShareCast

Latest Sareum Holdings Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Sareum Holdings Market Data

Currency UK Pounds
Share Price 18.00p
Change Today 0.50p
% Change 2.86 %
52 Week High 27.50p
52 Week Low 11.25p
Volume 142,218
Shares Issued 138.07m
Market Cap £24.85m
Beta 0.64
RiskGrade 594

Sareum Holdings Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
46.86% below the market average46.86% below the market average46.86% below the market average46.86% below the market average46.86% below the market average
2.44% below the sector average2.44% below the sector average2.44% below the sector average2.44% below the sector average2.44% below the sector average
Price Trend
27.48% below the market average27.48% below the market average27.48% below the market average27.48% below the market average27.48% below the market average
9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average
Income Not Available
Growth Not Available

Sareum Holdings Dividends

No dividends found

Trades for 12-Feb-2026

Time Volume / Share Price
16:20 2,346 @ 18.50p
16:20 10,000 @ 17.50p
15:48 374 @ 18.60p
14:55 20,000 @ 18.69p
14:43 10,000 @ 17.48p

Sareum Holdings Key Personnel

COO Timothy J Mitchell

Top of Page